120 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
less than 51% of the outstanding voting power of the surviving or resulting entity,
Page 4 of 29
the acquisition of all or a majority
424B3
elf8f 6wik4g3v6t
13 Nov 23
Prospectus supplement
5:05pm
8-K
EX-10.1
nzh7pyb pe32r0r480
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.2
rq0f4v57w6o8w2rr9n8
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.2
hyvfc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.3
oru9ip1hhw2byfd hda
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.1
lxqhf 2u7hlgvkgd7
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-4.3
tcce0hg7hy3g
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-99.1
o68zark1 ja1q
29 Sep 23
InMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update
5:18pm
8-K
EX-99.1
fdi80ma
16 May 23
InMed Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
1:47pm
424B3
bxka9yicq4gy4t0v0fo
15 Dec 22
Prospectus supplement
11:42am